These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 447793)

  • 21. Naloxone does not alter the effect of gamma aminobutyric acid derivative, baclofen, on GH release in man.
    Chiodera P; Volpi R; Coiro V; Barilli L; Rossi G; Roti E
    J Endocrinol Invest; 1983 Oct; 6(5):381-4. PubMed ID: 6319478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of GH response to the GABA-B agonist baclofen in patients with major depression.
    Marchesi C; Chiodera P; De Ferri A; De Risio C; Dassó L; Menozzi P; Volpi R; Coiro V
    Psychoneuroendocrinology; 1991; 16(6):475-9. PubMed ID: 1667334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different gamma-aminobutyric acid receptor subtypes are involved in the regulation of opiate-dependent and independent luteinizing hormone-releasing hormone secretion.
    Masotto C; Wisniewski G; Negro-Vilar A
    Endocrinology; 1989 Jul; 125(1):548-53. PubMed ID: 2544412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of gamma-aminobutyric acid on growth hormone and prolactin secretion in man: influence of pimozide and domperidone.
    Cavagnini F; Benetti G; Invitti C; Ramella G; Pinto M; Lazza M; Dubini A; Marelli A; Müller EE
    J Clin Endocrinol Metab; 1980 Oct; 51(4):789-92. PubMed ID: 7419665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers.
    Miell JP; Corder R; Pralong FP; Gaillard RC
    J Clin Endocrinol Metab; 1991 Mar; 72(3):675-81. PubMed ID: 1671785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arginine normalizes the growth hormone (GH) response to GH-releasing hormone in adult patients receiving chronic daily immunosuppressive glucocorticoid therapy.
    Giustina A; Bossoni S; Bodini C; Girelli A; Balestrieri GP; Pizzocolo G; Wehrenberg WB
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1301-5. PubMed ID: 1592874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine.
    Valcavi R; Valente F; Dieguez C; Zini M; Procopio M; Portioli I; Ghigo E
    J Clin Endocrinol Metab; 1993 Sep; 77(3):616-20. PubMed ID: 8103770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
    Cordido F; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a sex difference in the basal growth hormone response to GABAergic stimulation in humans.
    Monteleone P; Maj M; Iovino M; Steardo L
    Acta Endocrinol (Copenh); 1988 Nov; 119(3):353-7. PubMed ID: 2847468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of growth hormone secretion by alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in infantile, prepubertal, and adult male rats.
    González LC; Pinilla L; Tena-Sempere M; Aguilar E
    Endocrinology; 1999 Mar; 140(3):1279-84. PubMed ID: 10067854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gamma amino butyric acid (GABA) controls anterior pituitary hormone secretion.
    McCann SM; Rettori V
    Adv Biochem Psychopharmacol; 1986; 42():173-89. PubMed ID: 3020896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone does not inhibit its own secretion during prolonged hypoglycemia in man.
    Barbetti F; Crescenti C; Negri M; Leonetti F; Grossi A; Tamburrano G
    J Clin Endocrinol Metab; 1990 May; 70(5):1371-4. PubMed ID: 2110574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of some gamma-aminobutyric acid (GABA)-ergic drugs on the dopaminergic control of human growth hormone secretion.
    Koulu M; Lammintausta R; Dahlström S
    J Clin Endocrinol Metab; 1980 Jul; 51(1):124-9. PubMed ID: 6769935
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute administration of corticoids: a new and peculiar stimulus of growth hormone secretion in man.
    Casanueva FF; Burguera B; Muruais C; Dieguez C
    J Clin Endocrinol Metab; 1990 Jan; 70(1):234-7. PubMed ID: 2104624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dexamethasone inhibition of interferon-alpha 2-induced stimulation of cortisol and growth hormone secretion in chronic myeloproliferative syndrome.
    Barbarino A; Colasanti S; Corsello SM; Satta MA; Della Casa S; Rota CA; Tartaglione R; Barini A
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1329-32. PubMed ID: 7714107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
    Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the antihistaminic agents meclastine and dexchlorpheniramine on the response of human growth hormone to arginine infusion and insulin hypoglycemia.
    Pontiroli AE; Viberti G; Vicari A; Pozza G
    J Clin Endocrinol Metab; 1976 Sep; 43(3):582-6. PubMed ID: 956343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
    J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly.
    Kovacs M; Kineman RD; Schally AV; Zarandi M; Groot K; Frohman LA
    Endocrinology; 1997 Nov; 138(11):4536-42. PubMed ID: 9348175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults--a clinical research center study.
    Chapman IM; Hartman ML; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2874-80. PubMed ID: 8768844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.